CryoLife Heart Valves a Risk, FDA Says

CryoLife Inc.’s heart valves may carry a risk of infection for patients, so doctors should consider using other suppliers if possible, the Food and Drug Administration said.

CryoLife’s heart valves weren’t part of a recall earlier this month the FDA ordered for some of the company’s products earlier this month.

CryoLife officials couldn’t be reached for comment. CryoLife shares fell 29 cents to $3.68 on the NYSE.